Live Breaking News & Updates on Dilutive Interest Related|Page 4

Stay updated with breaking news from Dilutive interest related. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lysogene Secures a €4.3 Million Non-dilutive Financing From Bpifrance to Support Its Development

Financing composed of a €3.0 million R&D innovation loan and a 1.3 million reimbursable advance Cash position strengthened and runway extended Regulatory News: Lysogene (FR0013233475 LYS) ....

United States , France General , Sarepta Therapeutics Inc , Durant Des Aulnois , Chief Financial Officer , Sarepta Therapeutics , Looking Statement , French Autorit , Des March , French Markets Authorities , Financial Officer ,

Pherecydes Pharma Obtains €2 Million in Non-dilutive Financing From Bpifrance


Pherecydes Pharma Obtains €2 Million in Non-dilutive Financing From Bpifrance
Regulatory News:
Pherecydes Pharma (Paris:ALPHE)
(FR0011651694 ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announces that it has obtained, within the framework of a State-Guaranteed Loan Innovation Support , a €2 million loan from Bpifrance, the French public investment bank.
This interest-bearing loan benefits from a one-year deferred repayment and Pherecydes Pharma will have the possibility, after the first year, of amortizing the loan over a duration of up to 5 years.
Guy-Charles Fanneau de La Horie, Chairman of the Executive Board of Pherecydes Pharma, states: ....

Pherecydes Pharma , Philippe Rousseau , Nicolas Merigeau , Dusan Oresansky , Guaranteed Loan Innovation , Charles Fanneau De La Horie , Executive Board , Early Access Programs , French National Agency , பிலிப் ரூஸ்ஸோ , நிர்வாகி பலகை , ஆரம்ப நுழைவு ப்ரோக்ர்யாம்ஸ் ,